Monday, September 8, 2008
Why Suffer and Yet Sinusitis Treatments Are Here With Us
Antibiotics are the favorites among doctors when treating their patients. These include the Amoxillins which are seen to be the best treatment for bacterial infection. Just like any type of antibiotics, amoxillins are known to destroy the outer cell structures of the bacteria hence killing them in the process.Once the bacteria are dead, the infection can stop from spreading and instead get cured. Amoxillins can be purchased over from a drug store nearby when needed though they are to be taken according to the doctor's instructions.
Sunday, September 7, 2008
If You Suffer From Excessive Sweating Then You Must Read This
Excessive sweating is a significant health issue that many people suffer with throughout the world. In actual fact I think around one to three percent of the world's population suffer from what is known formally as "hyperhydrosis" I am afraid I do not have the silver bullet relative to this issue nor am I going to advice you medically about what to do. On the other hand I may be able to point a few things out that hopefully will give you some valuable food for thought.
Saturday, September 6, 2008
NIMS' Acceleration Therapeutic Platform: Potential Non-Invasive Home Treatment Of Coronary Artery Disease
Marvin A Sackner, M.D., CEO, Chairman of the Board, Non-Invasive Monitoring Systems, Inc. (NIMS) (OTCBB:NIMU) announced that Professor Masatoshi Fujita and associates, Shiga University of Medical Sciences, Kyoto University Graduate School of Medicine, Kitano Hospital, Japan presented a paper on NIMS' Whole Body Periodic Acceleration (WBPA) technology at the European Society of Cardiology meeting held in Munich, Germany August 30 to September 3, 2008. More at...
Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety endpoints in patients with multi-vessel disease and diabetes. These data were presented here recently at the European Society of Cardiology meeting. More at...
Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety endpoints in patients with multi-vessel disease and diabetes. These data were presented here recently at the European Society of Cardiology meeting. More at...
Subscribe to:
Posts (Atom)